Bladder cancer is a disease that negatively affects patients’ quality of life, but treatment options have remained unchanged for a long time. Although promising results have been achieved with current bladder cancer treatments, cancer recurrence, progression, and therapy resistance are the most severe problems preventing the efficiency of bladder cancer treatments. Autophagy refers to an evolutionarily conserved catabolic process in which proteins, damaged organelles, and cytoplasmic components are degraded by lysosomal enzymes. Autophagy regulates the therapeutic response to the chemotherapy drugs, thus determining the effect of therapy on cancer cells. Autophagy is a stress-induced cell survival mechanism and its excessive stimulation can cause resistance of tumor cells to therapeutic agents. Depending on the conditions, an increase in autophagy may cause treatment resistance or autophagic cell death, and it is related to important anti-cancer mechanisms, such as apoptosis. Therefore, understanding the roles of autophagy under different conditions is important for designing effective anti-cancer agents. The dual role of autophagy in cancer has attracted considerable attention in respect of bladder cancer treatment. In this review, we summarize the basic characteristics of autophagy, including its mechanisms, regulation, and functions, and we present examples from current studies concerning the dual role of autophagy in bladder cancer progression and therapy.
Babjuk M, Burger M, Compérat EM, Gontero P, Mostafid AH, Palou J, van Rhijn BWG, Rouprêt M, Shariat SF, Sylvester R, Capoun O, Cohen D, Escrig JLD, Seisen T, Soukup V. Non-muscle-invasive Bladder Cancer Guidelines Panel. EAU Guidelines on Non-muscle-invasive Bladder Cancer. Edn. presented at the EAU Annual Congress Amsterdam 2020. ISBN 978-94-92671-03-3
2.
BrayFFerlayJSoerjomataramISiegelRLTorreLAJemalA.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin2018;
68:394–424
3.
KobayashiTOwczarekTBMcKiernanJM,
Abate-Shen C. Modelling bladder cancer in mice: opportunities and challenges. Nat Rev Cancer2015;
15:42–54
4.
LiXHeSMaB.Autophagy and autophagy-related proteins in cancer. Mol Cancer2020;
19:12
5.
MarinkovićMŠprungMBuljubašićMNovakI.Autophagy modulation in cancer: current knowledge on action and therapy. Oxid Med Cell Longev2018;
2018:8023821
6.
Kalai SelviSVinothAVaradharajanTWengCF,
Vijaya Padma V. Neferine augments therapeutic efficacy of cisplatin through ROS-mediated non-canonical autophagy in human lung adenocarcinoma (A549 cells). Food Chem Toxicol2017;
103:28–40
7.
VarolNKonacEBilenCY.Does Wnt/β-catenin pathway contribute to the stability of DNMT1 expression in urological cancer cell lines?Exp Biol Med2015;
240:624–30
8.
KonacEVarolNKilicciogluIBilenCY.Synergistic effects of cisplatin and proteasome inhibitor bortezomib on human bladder cancer cells. Oncol Lett2015;
10:560–4
9.
KurmanYKilicciogluIDikmenAUEsendagliGBilenCYSozenSKonacE.Cucurbitacin B and cisplatin induce the cell death pathways in MB49 mouse bladder cancer model. Exp Biol Med2020;
245:805–14
10.
HillSMWrobelLRubinszteinDC.Post-translational modifications of beclin 1 provide multiple strategies for autophagy regulation. Cell Death Differ2019;
26:617–29
11.
SinghSSVatsSChiaAYTanTZDengSOngMSArfusoFYapCTGohBCSethiGHuangRYShenHMManjithayaRKumarAP.Dual role of autophagy in hallmarks of cancer. Oncogene2018;
37:1142–58
12.
DossouASBasuA.The emerging roles of mTORC1 in macromanaging autophagy. Cancers2019;
11:1422
13.
SuiXChenRWangZHuangZKongNZhangMHanWLouFYangJZhangQWangXHeCPanH.Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis2013;
4:e838
14.
ZhangJWangGZhouYChenYOuyangLLiuB.Mechanisms of autophagy and relevant small-molecule compounds for targeted cancer therapy. Cell Mol Life Sci2018;
75:1803–26
15.
EfeyanAZoncuRSabatiniDM.Amino acids and mTORC1: from lysosomes to disease. Trends Mol Med2012;
18:524–33
16.
SunJFengYWangYJiQCaiGShiLWangYHuangYZhangJLiQ.α-hederin induces autophagic cell death in colorectal cancer cells through reactive oxygen species dependent AMPK/mTOR signaling pathway activation. Int J Oncol2019;
54:1601–12
17.
QianHRShiZQZhuHPGuLHWangXFYangY.Interplay between apoptosis and autophagy in colorectal cancer. Oncotarget2017;
8:62759–68
18.
KrielJLoosB.The good, the bad and the autophagosome: exploring unanswered questions of autophagy-dependent cell death. Cell Death Differ2019;
26:640–52
19.
ZhuJSOuyangDYShiZJXuLHZhangYTHeXH.Cucurbitacin B induces cell cycle arrest, apoptosis and autophagy associated with G actin reduction and persistent activation of cofilin in jurkat cells. Pharmacology2012;
89:348–56
20.
HasimaNOzpolatB.Regulation of autophagy by polyphenolic compounds as a potential therapeutic strategy for cancer. Cell Death Dis2014;
5:e1509
21.
YuHWuCLWangXBanQQuanCLiuMDongHLiJKimGYChoiYHWangZJinCY.SP600125 enhances C-2-induced cell death by the switch from autophagy to apoptosis in bladder cancer cells. J Exp Clin Cancer Res2019;
38:1–13
22.
GewirtzDA.The four faces of autophagy: implications for cancer therapy. Cancer Res2014;
74:647–51
23.
DengSShanmugamMKKumarAPYapCTSethiGBishayeeA.Targeting autophagy using natural compounds for cancer prevention and therapy. Cancer2019;
125:1228–46
24.
YueZJinSYangCLevineAJHeintzN.Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci U S A2003;
100:15077–82
25.
QuXYuJBhagatGFuruyaNHibshooshHTroxelARosenJEskelinenELMizushimaNOhsumiYCattorettiGLevineB.Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest2003;
112:1809–20
26.
DingZBShiYHZhouJQiuSJXuYDaiZShiGMWangXYKeAWWuBFanJ.Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinoma. Cancer Res2008;
68:9167–75
27.
AhnCHJeongEGLeeJWKimMSKimSHKimSSYooNJLeeSH.Expression of beclin-1, an autophagy-related protein, in gastric and colorectal cancers. APMIS2007;
115:1344–9
28.
LiuGHZhongQYeYLWangHBHuLJQinZKZengMSZengBH.Expression of beclin 1 in bladder cancer and its clinical significance. Int J Biol Markers2013;
28:56–62
29.
BaspinarSBircanSYavuzGKapucuogluN.Beclin 1 and bcl-2 expressions in bladder urothelial tumors and their association with clinicopathological parameters. Pathol Res Pract2013;
209:418–23
30.
ChenLLiuYZhangQZhangMHanXLiQXieTWuQSuiX.p53/PCDH17/beclin-1 proteins as prognostic predictors for urinary bladder cancer. J Cancer2019;
10:6207–16
31.
ZhuJLiYTianZHuaXGuJLiJLiuCJinHWangYJiangGHuangHHuangC.ATG7 overexpression is crucial for tumorigenic growth of bladder cancer in vitro and in vivo by targeting the ETS2/miRNA196b/FOXO1/p27 axis. Mol Ther Nucleic Acids2017;
7:299–313
32.
ChangYYanWHeXZhangLLiCHuangHNaceGGellerDALinJTsungA.miR-375 inhibits autophagy and reduces viability of hepatocellular carcinoma cells under hypoxic conditions. Gastroenterology2012;
143:177–87
ZhangJMaoSWangLZhangWZhangZGuoYWuYYiFYaoX.MicroRNA-154 functions as a tumor suppressor in bladder cancer by directly targeting ATG7. Oncol Rep2019;
41:819–28
35.
ZhuJTianZLiYHuaXZhangDLiJJinHXuJChenWNiuBWuXRCominciniSHuangHHuangC.ATG7 promotes bladder cancer invasion via autophagy‐mediated increased ARHGDIB mRNA stability. Adv Sci2019;
6:1801927
36.
ZhuJLiYLuoYXuJLiufuHTianZHuangCLiJHuangC.A feedback loop formed by ATG7/autophagy, FOXO3a/miR-145 and PD-L1 regulates Stem-Like properties and invasion in human bladder cancer. Cancers2019;
11:349
37.
ZhuJHuangGHuaXLiYYanHCheXTianZLiufuHHuangCLiJXuJDaiWHuangHHuangC.CD44s is a crucial ATG7 downstream regulator for stem-like property, invasion, and lung metastasis of human bladder cancer (BC) cells. Oncogene2019;
38:3301–15
38.
BuffenKOostingMQuintinJNgAKleinnijenhuisJKumarVvan de VosseEWijmengaCvan CrevelROosterwijkEGrotenhuisAJVermeulenSHKiemeneyLAvan de VeerdonkFLChamilosGXavierRJvan der MeerJWNeteaMGJoostenLA.Autophagy controls BCG-induced trained immunity and the response to intravesical BCG therapy for bladder cancer. PLoS Pathog2014;
10:e1004485
39.
KungCPBudinaABalaburskiGBergenstockMKMurphyM.Autophagy in tumor suppression and cancer therapy. Crit Rev Eukaryot Gene Expr2011;
21:71–100
40.
WangSSChenGLiSHPangJSCaiKTYanHBHuangZGHeRQ.Identification and validation of an individualized autophagy-clinical prognostic index in bladder cancer patients. Onco Targets Ther2019;
12:3695–712
41.
KimSLeeAJYeoMKNaYGKimJYChoMJKimJSJoEKKimJM.Clinicopathological profiling of LC3B, an autophagy marker, and ESRRA (estrogen-related receptor-alpha) in muscle-invasive bladder cancer. Anticancer Res2018;
38:2429–37
42.
ShrivastavaSMansureJJAlmajedWCuryFFerbeyreGPopovicMSeuntjensJKassoufW.The role of HMGB1 in radioresistance of bladder cancer. Mol Cancer Ther2016;
15:471–9
43.
YinHYangXGuWLiuYLiXHuangXZhuXTaoYGouXHeW.HMGB1-mediated autophagy attenuates gemcitabine-induced apoptosis in bladder cancer cells involving JNK and ERK activation. Oncotarget2017;
8:71642–56
44.
YangXYinHZhangYLiXTongHZengYWangQHeW.Hypoxia-induced autophagy promotes gemcitabine resistance in human bladder cancer cells through hypoxia-inducible factor 1α activation. Int J Oncol2018;
53:215–24
45.
ZengQLiuJCaoPLiJLiuXFanXLiuLChengYXiongWLiJBoHZhuYYangFHuJZhouMZhouYZouQZhouJCaoK.Inhibition of REDD1 sensitizes bladder urothelial carcinoma to paclitaxel by inhibiting autophagy. Clin Cancer Res2018;
24:445–59
46.
KimMJHwangGYChoMJChiBHParkSIChangIHWhangYM.Depletion of NBR1 in urothelial carcinoma cells enhances rapamycin‐induced apoptosis through impaired autophagy and mitochondrial dysfunction. J Cell Biochem2019;
120:19186–201
47.
VanzoRBartkovaJMerchut-MayaJMHallABouchalJDyrskjøtLFrankelLBGorgoulisVMaya-MendozaAJäätteläMBartekJ.Autophagy role (s) in response to oncogenes and DNA replication stress. Cell Death Differ2020;
27:1134–53
48.
LiTJiangDWuK.p62 promotes bladder cancer cell growth by activating KEAP1/NRF2‐dependent antioxidative response. Cancer Sci2020;
111:1156–64
49.
ZhangCLeiJLZhangHXiaYZYuPYangLKongLY.Calyxin Y sensitizes cisplatin-sensitive and resistant hepatocellular carcinoma cells to cisplatin through apoptotic and autophagic cell death via SCF βTrCP-mediated eEF2K degradation. Oncotarget2017;
8:70595–616
50.
OjhaRJhaVSinghSK.Gemcitabine and mitomycin induced autophagy regulates cancer stem cell pool in urothelial carcinoma cells. Biochim Biophys Acta2016;
1863:347–59
51.
PanXWLiLHuangYHuangHXuDFGaoYChenLRenJZCaoJWHongYCuiXG.Icaritin acts synergistically with epirubicin to suppress bladder cancer growth through inhibition of autophagy. Oncol Rep2016;
35:334–42
52.
ZhangHHHuangBCaoYHLiQXuHF.Role of 5-Aza-CdR in mitomycin-C chemosensitivity of T24 bladder cancer cells. Oncol Lett2017;
14:5652–6
53.
LinYCLinJFWenSIYangSCTsaiTFChenHEChouKYHwangTI.Chloroquine and hydroxychloroquine inhibit bladder cancer cell growth by targeting basal autophagy and enhancing apoptosis. Kaohsiung J Med Sci2017;
33:215–23
54.
WangFTangJLiPSiSYuHYangXTaoJLvQGuMYangHWangZ.Chloroquine enhances the radiosensitivity of bladder cancer cells by inhibiting autophagy and activating apoptosis. Cell Physiol Biochem2018;
45:54–66
55.
KurokiHAnrakuTKazamaABilimVTasakiMSchmittDMazarAPGilesFJUgolkovATomitaY.9-ING-41, a small molecule inhibitor of GSK-3beta, potentiates the effects of anticancer therapeutics in bladder cancer. Sci Rep2019;
9:19977
56.
Jiménez-GuerreroRGascaJFloresMLPérez-ValderramaBTejera-ParradoCMedinaRTortoleroMRomeroFJapónMASáezC.Obatoclax and paclitaxel synergistically induce apoptosis and overcome paclitaxel resistance in urothelial cancer cells. Cancers2018;
10:490
57.
KangMLeeKHLeeHSJeongCWKwakCKimHHKuJH.Concurrent autophagy inhibition overcomes the resistance of epidermal growth factor receptor tyrosine kinase inhibitors in human bladder cancer cells. Int J Mol Sci2017;
18:321
58.
OjhaRSinghSKBhattacharyyaSDhandaRSRakhaAMandalAKJhaV.Inhibition of grade dependent autophagy in urothelial carcinoma increases cell death under nutritional limiting condition and potentiates the cytotoxicity of chemotherapeutic agent. J Urol2014;
191:1889–98
59.
OjhaRSinghSKBhattacharyyaS.JAK-mediated autophagy regulates stemness and cell survival in cisplatin resistant bladder cancer cells. Biochim Biophys Acta2016;
1860:2484–97
60.
LiaoHXiaoYHuYXiaoYYinZLiuL.Suppression of cellular proliferation and invasion by HMGB1 knockdown in bladder urothelial carcinoma cells. Oncol Res2014;
22:235–45
61.
LinJFLinYCTsaiTFChenHEChouKYHwangTI.Cisplatin induces protective autophagy through activation of BECN1 in human bladder cancer cells. Drug Des Devel Ther2017;
11:1517–33
62.
ZengLPHuZMLiKXiaK.miR‐222 attenuates cisplatin‐induced cell death by targeting the PPP2R2A/akt/mTOR axis in bladder cancer cells. J Cell Mol Med2016;
20:559–67
63.
PengMWangJZhangDJinHLiJWuXRHuangC.PHLPP2 stabilization by p27 mediates its inhibition of bladder cancer invasion by promoting autophagic degradation of MMP2 protein. Oncogene2018;
37:5735–48
64.
LiFZengJGaoYGuanZMaZShiQDuCJiaJXuSWangXChangLHeDGuoP.G9a inhibition induces autophagic cell death via AMPK/mTOR pathway in bladder transitional cell carcinoma. PLoS One2015;
10:e0138390
65.
JinHMaJXuJLiHChangYZangNTianZWangXZhaoNLiuLChenCXieQLuYFangZHuangXHuangCHuangH.Oncogenic role of MIR516A in human bladder cancer was mediated by its attenuating PHLPP2 expression and BECN1-dependent autophagy. Autophagy2020;doi: 10.1080/15548627.2020.1733262
66.
ZhangHHHuangZXZhongSQFeiKLCaoYH.miR-21 inhibits autophagy and promotes malignant development in the bladder cancer T24 cell line. Int J Oncol2020;
56:986–98
67.
JinLYuanFDaiGYaoQXiangHWangLXueBShanYLiuX.Blockage of O-linked GlcNAcylation induces AMPK-dependent autophagy in bladder cancer cells. Cell Mol Biol Lett2020;
25:17
68.
LiJRChengCLYangWJYangCROuYCWuMJKoJL.FIP-gts potentiate autophagic cell death against cisplatin-resistant urothelial cancer cells. Anticancer Res2014;
34:2973–83
69.
HsinILWangSCLiJRCiouTCWuCHWuHMKoJL.Immunomodulatory proteins FIP-gts and chloroquine induce caspase-independent cell death via autophagy for resensitizing cisplatin-resistant urothelial cancer cells. Phytomedicine2016;
23:1566–73
70.
LiJRChengCLYangCROuYCWuMJKoJL.Dual inhibitor of phosphoinositide 3-kinase/mammalian target of rapamycin NVP-BEZ235 effectively inhibits cisplatin-resistant urothelial cancer cell growth through autophagic flux. Toxicol Lett2013;
220:267–76
71.
ChenCHChangouCAHsiehTHLeeYCChuCYHsuKCWangHCLinYCLoYNLiuYRLiouJPYenY.Dual inhibition of PIK3C3 and FGFR as a new therapeutic approach to treat bladder cancer. Clin Cancer Res2018;
24:1176–89
72.
YanSYangXChenTXiZJiangX.The PPARγ agonist troglitazone induces autophagy, apoptosis and necroptosis in bladder cancer cells. Cancer Gene Ther2014;
21:188–93
73.
LiangYZhuJHuangHXiangDLiYZhangDLiJWangYJinHJiangGLiuZHuangC.SESN2/sestrin 2 induction-mediated autophagy and inhibitory effect of isorhapontigenin (ISO) on human bladder cancers. Autophagy2016;
12:1229–39
74.
FangCYChenJSChangSKShenCH.Reversine induces autophagic cell death through the AMP-activated protein kinase pathway in urothelial carcinoma cells. Anticancer Drugs2018;
29:29–39
75.
HuaXXuJDengXXuJLiJZhuDQZhuJJinHTianZHuangHZhaoQSHuangC.New compound ChlA-F induces autophagy-dependent anti-cancer effect via upregulating sestrin-2 in human bladder cancer. Cancer Lett2018;
436:38–51
76.
WangFCaoMFanMWuHHuangWZhangYHuZJinX.AMPK-mTOR-ULK1 axis activation-dependent autophagy promotes hydroxycamptothecin-induced apoptosis in human bladder cancer cells. J Cell Physiol2020;
235:4302–15
77.
KouBLiuWXuXYangYYiQGuoFLiJZhouJKouQ.Autophagy induction enhances tetrandrine-induced apoptosis via the AMPK/mTOR pathway in human bladder cancer cells. Oncol Rep2017;
38:3137–43
78.
ShinSSParkYJHwangBParkSLHanSWParkSSChoiYHKimWJMoonSK.Triacanthine exerts antitumor effects on bladder cancer in vitro and in vivo. Phytomedicine2019;
64:153069
79.
LiFYangCZhangHBMaJJiaJTangXZengJChongTWangXHeDGuoP.BET inhibitor Q1 suppresses cell proliferation via inducing autophagy and activating LKB1/AMPK in bladder cancer cells. Cancer Med2019;
8:4792–805
80.
XiongQLiuARenQXueYYuXYingYGaoHTanHZhangZLiWZengSXuC.Cuprous oxide nanoparticles trigger reactive oxygen species-induced apoptosis through activation of ERK-dependent autophagy in bladder cancer. Cell Death Dis2020;
11:366
81.
WangFWuHFanMYuRZhangYLiuJZhouXCaiYHuangSHuZJinX.Sodium butyrate inhibits migration and induces AMPK‐mTOR pathway‐dependent autophagy and ROS‐mediated apoptosis via the miR‐139‐5p/bmi‐1 axis in human bladder cancer cells. FASEB J2020;
34:4266–82
82.
DuanFMeiCYangLZhengJLuHXiaYHsuSLiangHHongL.Vitamin K2 promotes PI3K/AKT/HIF-1α-mediated glycolysis that leads to AMPK-dependent autophagic cell death in bladder cancer cells. Sci Rep2020;
10:7714
83.
MaJQiJLiSZhangCWangHShaoLYuanXShaQ.Desloratadine, a novel antigrowth reagent for bladder cancer. Technol Cancer Res Treat2020;
19:1533033820926591
84.
XuAYangGGZhangYZhaoST.Heptaphylline suppresses the proliferation and migration of human bladder cancer cells via induction of intrinsic apoptosis, autophagy and inhibition of β-catenin signalling pathway. J Buon2020;
25:274–9
